09.18.17
Emerald Kalama Chemical completed start-up of its $40 million expansion at the company’s Rotterdam, Netherlands site. The fully operational expansion increases Emerald’s global capabilities, manufacturing flexibility and capacity for Purox B Benzoic Acid, Kalama Benzaldehyde and many downstream products, such as Kalama Hexyl Cinnamic Aldehyde (HCA) and Kalama Amyl Cinnamic Aldehyde (ACA).
The additional operations in Rotterdam support the company’s strategic vision to sustain a leadership position in benzoic acid, benzaldehyde and downstream products such as HCA. The project not only significantly expands capacity for these products, but also enhances Emerald’s global footprint and backward integration in key raw materials.
Emerald is the only global HCA and ACA producer manufacturing these key aroma chemicals in two major regions – with North American operations in the US and European operations in the UK, the company noted.
The additional operations in Rotterdam support the company’s strategic vision to sustain a leadership position in benzoic acid, benzaldehyde and downstream products such as HCA. The project not only significantly expands capacity for these products, but also enhances Emerald’s global footprint and backward integration in key raw materials.
Emerald is the only global HCA and ACA producer manufacturing these key aroma chemicals in two major regions – with North American operations in the US and European operations in the UK, the company noted.